Literature DB >> 6336952

Acyclovir (Zovirax) in herpetic disciform keratitis.

L M Collum, P Logan, T Ravenscroft.   

Abstract

Forty patients with disciform keratitis were randomly assigned to double-blind treatment with 3% acyclovir and 0.01% betamethasone drops or acyclovir and matching placebo. All patients who received the combination healed in a median time of 21 days, while 11 of 19 patients who received acyclovir alone were withdrawn because their condition remained static or worsened (p less than 0.001). The combination therapy produced a faster rate of healing (p = 0.004); other clinical parameters also improved more favourably in the combination treatment group. Three patients had mild transient punctate keratopathy, but no serious adverse effects were seen despite treatment for a median duration of 28 days in the acyclovir group and 38 days in the combined therapy group. A combination of acyclovir and dilute steroid drops is effective in the management of disciform keratitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336952      PMCID: PMC1039978          DOI: 10.1136/bjo.67.2.115

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Editorial: Herpetic stromal disease.

Authors:  H E Kaufman
Journal:  Am J Ophthalmol       Date:  1975-12       Impact factor: 5.258

2.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

4.  A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis.

Authors:  D J Coster; K R Wilhelmus; R Michaud; B R Jones
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

5.  Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers.

Authors:  J McGill; P Tormey; C B Walker
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

6.  A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration.

Authors:  B J Young; A Patterson; T Ravenscroft
Journal:  Br J Ophthalmol       Date:  1982-06       Impact factor: 4.638

7.  Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

Authors:  L M Collum; A Benedict-Smith; I B Hillary
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

8.  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers.

Authors:  B R Jones; D J Coster; P N Fison; G M Thompson; L M Cobo; M G Falcon
Journal:  Lancet       Date:  1979-02-03       Impact factor: 79.321

9.  Acyclovir and vidarabine in the treatment of ulcerative herpes simplex keratitis.

Authors:  D Pavan-Langston; J Lass; M Hettinger; I Udell
Journal:  Am J Ophthalmol       Date:  1981-12       Impact factor: 5.258

10.  [Superficial herpes simplex keratitis. Double-blind comparative trial of acyclovir and idoxuridine (author's transl)].

Authors:  J Colin; A Tournoux; C Chastel; G Renard
Journal:  Nouv Presse Med       Date:  1981-10-10
  10 in total
  13 in total

1.  A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis.

Authors:  S M Porter; A Patterson; P Kho
Journal:  Br J Ophthalmol       Date:  1990-05       Impact factor: 4.638

2.  A comparative analysis over a decade of the changing indications for penetrating keratoplasty in Ireland.

Authors:  L M Collum; J Mullaney; M A McDermott; M Hillery; P Mullaney
Journal:  Ir J Med Sci       Date:  1987-09       Impact factor: 1.568

3.  Severe herpetic keratitis. I: Prevalence of visual impairment in a clinic population.

Authors:  C M Claoué; M J Ménage; D L Easty
Journal:  Br J Ophthalmol       Date:  1988-07       Impact factor: 4.638

Review 4.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

5.  Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration.

Authors:  L M Collum; P Logan; D McAuliffe-Curtin; S O Hung; A Patterson; P J Rees
Journal:  Br J Ophthalmol       Date:  1985-11       Impact factor: 4.638

Review 6.  Rational acyclovir therapy in herpetic eye disease.

Authors:  M G Falcon
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

7.  Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.

Authors:  W J Power; A Benedict-Smith; M Hillery; K Brady; L M Collum
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

8.  The current management of herpetic eye disease.

Authors:  L M Collum; W J Power; A Collum
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

9.  Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis.

Authors:  W J Power; M P Hillery; A Benedict-Smith; L M Collum
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

Review 10.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.